1. Home
  2. HFFG vs MNOV Comparison

HFFG vs MNOV Comparison

Compare HFFG & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$1.50

Market Cap

80.7M

ML Signal

HOLD

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.32

Market Cap

67.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFFG
MNOV
Founded
1997
2000
Country
United States
United States
Employees
960
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.7M
67.9M
IPO Year
2016
2004

Fundamental Metrics

Financial Performance
Metric
HFFG
MNOV
Price
$1.50
$1.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$6.00
$7.50
AVG Volume (30 Days)
113.7K
36.0K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
20.65
N/A
EPS
0.02
N/A
Revenue
$1,228,282,000.00
$2,360,807.00
Revenue This Year
$5.59
N/A
Revenue Next Year
$2.24
$180.00
P/E Ratio
$75.00
N/A
Revenue Growth
2.21
194.15
52 Week Low
$1.38
$1.17
52 Week High
$3.86
$1.96

Technical Indicators

Market Signals
Indicator
HFFG
MNOV
Relative Strength Index (RSI) 37.96 47.47
Support Level $1.40 $1.30
Resistance Level $2.30 $1.46
Average True Range (ATR) 0.08 0.04
MACD -0.01 -0.00
Stochastic Oscillator 11.54 33.33

Price Performance

Historical Comparison
HFFG
MNOV

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, frozen and dry food, and non-food products to Asian restaurants and other foodservice customers throughout the United States. The company's business consists of one operating segment: HF Group, which operates solely in the United States. The company's product list consists of Meat, Poultry & Seafood, Sauces & Oils, Takeout Items (Boxes, Chopsticks & Utensils), Raw Ingredients (Flour, Cornstarch, Spices), Cleaning Supplies, and Rice & Grains.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: